跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 68 条关于
“22q11.2 microdeletion”
全部
68
临床试验
56
药物
3
机构
0
资讯
9
4个月前
BillionToOne Launches Unity Confirm: Non-Invasive Fetal Cell Test Bridges Gap Between Screening and Invasive Diagnostics
去年
Myriad Genetics Launches FirstGene Multiple Prenatal Screen with Four-in-One Testing Capability
上个月
Antioxidant Therapy Bypasses Genetic Defect in 22q11.2 Deletion Syndrome via Alternative Gene Networks
去年
Nobias Therapeutics' NB-001 Shows Promise for 22q11.2 Deletion Syndrome
去年
Myriad Genetics Advances Early Pregnancy Screening with Eight-Week NIPT Study Results
上个月
Synaptiq Therapeutics Launches with Acquisition of SYN-001, a Phase II-Ready Small Molecule for 22q11.2 Deletion Syndrome
去年
Harmony Biosciences Reports Strong Q3 2024 Results and Pipeline Advancements
3个月前
Brain Scans Reveal Two Distinct Biological Subtypes of Autism
2个月前
Combined Newborn Screening for SMA and SCID in Italy Achieves 100% Positive Predictive Value Over Five Years